{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T09:55:56Z","timestamp":1758448556203,"version":"3.44.0"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"publisher","award":["NRF-2020R1C1C1009294"],"award-info":[{"award-number":["NRF-2020R1C1C1009294"]}],"id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.jns.2022.120457","type":"journal-article","created":{"date-parts":[[2022,10,8]],"date-time":"2022-10-08T10:43:08Z","timestamp":1665225788000},"page":"120457","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Cilostazol-based dual anti-platelet agents for Asian patients: An updated network meta-analysis"],"prefix":"10.1016","volume":"442","author":[{"given":"Seung Jin","family":"Jung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Ryul","family":"Shim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bum Joon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Man","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2022","key":"10.1016\/j.jns.2022.120457_bb0005","doi-asserted-by":"crossref","first-page":"166","DOI":"10.5853\/jos.2021.02628","article-title":"Update of the Korean clinical practice guidelines for stroke: antithrombotic therapy for patients with acute ischemic stroke or transient ischemic attack","volume":"24","author":"Park","year":"2022","journal-title":"J. Stroke."},{"key":"10.1016\/j.jns.2022.120457_bb0010","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1161\/CIRCULATIONAHA.113.003187","article-title":"Early dual versus mono antiplatelet therapy for acute non-cardioembolic ischemic stroke or transient ischemic attack: an updated systematic review and meta-analysis","volume":"128","author":"Wong","year":"2013","journal-title":"Circulation."},{"key":"10.1016\/j.jns.2022.120457_bb0015","doi-asserted-by":"crossref","first-page":"463","DOI":"10.7326\/0003-4819-159-7-201310010-00006","article-title":"Risk-benefit profile of long-term dual- versus single-antiplatelet therapy among patients with ischemic stroke: a systematic review and meta-analysis","volume":"159","author":"Lee","year":"2013","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jns.2022.120457_bb0020","doi-asserted-by":"crossref","first-page":"753","DOI":"10.21037\/atm-20-7951","article-title":"Antiplatelet regimens for Asian patients with ischemic stroke or transient ischemic attack: a systematic review and network meta- analysis","volume":"9","author":"Jung","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.jns.2022.120457_bb0025","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S1474-4422(19)30148-6","article-title":"Dual antiplatelet therapy using cilostazol for secondary prevention in patients with high-risk ischaemic stroke in Japan: a multicentre, open-label, randomised controlled trial","volume":"18","author":"Toyoda","year":"2019","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jns.2022.120457_bb0030","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.1161\/STROKEAHA.121.034378","article-title":"Dual antiplatelet therapy using Cilostazol with aspirin or Clopidogrel: subanalysis of the CSPS.com trial","volume":"52","author":"Hoshino","year":"2021","journal-title":"Stroke."},{"key":"10.1016\/j.jns.2022.120457_bb0035","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1161\/STROKEAHA.119.026655","article-title":"Cilostazol mono and combination treatments in ischemic stroke: an updated systematic review and meta-analysis","volume":"50","author":"Kim","year":"2019","journal-title":"Stroke."},{"key":"10.1016\/j.jns.2022.120457_bb0040","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","article-title":"Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials","volume":"373","author":"Baigent","year":"2009","journal-title":"Lancet."},{"key":"10.1016\/j.jns.2022.120457_bb0045","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1056\/NEJM199309023291001","article-title":"An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction","volume":"329","author":"GUSTO investigators","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2022.120457_bb0050","doi-asserted-by":"crossref","first-page":"245","DOI":"10.21037\/atm-21-3748","article-title":"Antiplatelet regimens after ischemic stroke or transient ischemic attack: a systematic review and updated network meta-analysis","volume":"10","author":"Jung","year":"2022","journal-title":"Ann. Transl. Med."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X22003197?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X22003197?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T16:03:55Z","timestamp":1758384235000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X22003197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":10,"alternative-id":["S0022510X22003197"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2022.120457","relation":{},"ISSN":["0022-510X"],"issn-type":[{"type":"print","value":"0022-510X"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cilostazol-based dual anti-platelet agents for Asian patients: An updated network meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2022.120457","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"120457"}}